Author: Panome Bio

Posted Date:

March 5, 2026

Panome Bio Launches Exposomics Services to Measure the Chemical Drivers of Human Disease

Panome Bio

March 5, 2026
Panome Bio Introduces MassID™, a Major Advance in Untargeted Metabolomics Data Analysis for Biomarker Discovery and Drug Development

Panome Bio

February 25, 2026